1. Induction of Fas (CD95/APO-1) ligand is essential for p53-dependent apoptosis in an in vitro renal carcinoma model system

   • Toshihiko Okazaki
   • Daitoku Sakamuro

   Original Paper 16 May 2007 Pages: 581 - 588

   

2. Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs)

   • Piotr Rutkowski
   • Zbigniew I. Nowecki
   • Włodzimierz Ruka

   Original Paper 26 April 2007 Pages: 589 - 597

   

3. Potential tumor markers for human gastric cancer: an elevation of glycan:sulfotransferases and a concomitant loss of α1,2-fucosyltransferase activities

   • E. V. Chandrasekaran
   • Jun Xue
   • Khushi L. Matta

   Original Paper 11 May 2007 Pages: 599 - 611

   

4. A comprehensive salivary analysis for oral cancer diagnosis

   • Thomas Shpitzer
   • Gideon Bahar
   • Rafael M. Nagler

   Original Paper 04 May 2007 Pages: 613 - 617

   

5. Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma

   • M. Hartmann
   • M. Fedders
   • H. Oelschläger

   Original Paper 26 April 2007 Pages: 619 - 625

6. Glutathione peroxidase, glutathione reductase and protein oxidation in patients with glioblastoma multiforme and transitional meningioma

   • Taner Tanriverdi
   • Hakan Hanimoglu
   • Mehmet Yasar Kaynar

   Original Paper 25 April 2007 Pages: 627 - 633

   

7. KDR expression is associated with the stage and cigarette smoking of the patients with lung cancer

   • She-Juan An
   • Qiang Nie
   • Yi-Long Wu

   Original Paper 04 May 2007 Pages: 635 - 642

   

8. Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma

   • Azizbek Ramankulov
   • Michael Lein
   • Klaus Jung

   Original Paper 04 May 2007 Pages: 643 - 652

   

9. Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial

   • Thorsten Simon
   • Alfred Längler
   • Barbara Hero

   Original Paper 04 May 2007 Pages: 653 - 661

   

10. Analysing protein–protein interaction networks of human liver cancer cell lines with diverse metastasis potential

    • Hai-jun Zhou
    • Yin-kun Liu
    • Kun Guo

    Original Paper 26 April 2007 Pages: 663 - 672

    

11. Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study

    • Walter J. Koskinen
    • Kjell Brøndbo
    • Leena-Maija Aaltonen

    Original Paper 08 May 2007 Pages: 673 - 678